In recent news, Hormone Replacement Therapy (HRT) has been making headlines due to various developments and discussions surrounding its use. One notable event is the UK government's decision to restrict the dispensing of Utrogestan, an HRT medicine, to two-month prescriptions due to a supply shortage. This move has raised concerns among women who rely on this medication to manage their menopause symptoms.
Another significant development is the launch of a new scheme in the UK, starting from April 1, which allows women prescribed HRT as part of menopause treatment to access a year's worth of treatment for just under £20. This initiative aims to make HRT more affordable and accessible for women who require it.
Furthermore, there has been ongoing research exploring the potential benefits and risks associated with HRT. A Danish study has suggested a link between HRT use and an increased risk of dementia, while other studies have indicated a potential positive impact of HRT on reducing the risk of Alzheimer's disease in certain high-risk women.
HRT, also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT, PMHT), is a form of hormone therapy used to alleviate symptoms associated with female menopause. These symptoms can include hot flashes, night sweats, mood swings, and vaginal dryness. HRT typically involves the administration of estrogen and progesterone (or estrogen alone for women who have had a hysterectomy) to replace the declining hormone levels during menopause.
It is important to note that the decision to use HRT should be made in consultation with a healthcare professional, taking into consideration an individual's medical history, risk factors, and potential benefits and risks associated with the treatment.
-
The Chartered Institute of Personnel and Development (CIPD) report highlights the negative experiences women face at work due to menstrual symptoms.
-
Campaigners and MPs are advocating for menopause checks to be included in the NHS Health Check for women over 40.
-
A Danish study suggests a link between HRT use and an increased risk of dementia.
-
The UK government has restricted the dispensing of Utrogestan, an HRT medicine for menopause symptoms, to two-month prescriptions due to a supply shortage.
-
The NHS Business Services Authority (NHSBSA) website crashed just hours after the scheme's launch, leaving women unable to access the certificate that offers HRT prescriptions at a reduced cost.
-
From April 1, women prescribed HRT as part of menopause treatment will be able to access a new scheme to give them access to a year's worth of treatment for just under £20.
-
Prescriptions for testosterone gel for women have increased tenfold since November 2015
-
Nicola Bulley, a mother-of-two, went missing after stopping her menopause medication, leading to concerns about her well-being.
-
Researchers find that hormone replacement therapy may have a positive impact on Alzheimer's risk in higher-risk women.
-
Researchers from the University of East Anglia and the University of Edinburgh have found evidence of the potential importance of hormone replacement therapy (HRT) in reducing the risk of Alzheimer's disease in women carrying the APOE4 gene.
-
Pharmacists report shortages of common cough and cold medicines in the UK.
-
Women are experiencing a range of health issues during menopause, including bladder leaks, hair loss, and endometriosis.
-
The all-party parliamentary group (APPG) on the menopause has called for immediate action to improve care for women going through menopause.
-
Boots begins selling HRT over the counter without a prescription